- Accesswire•3 days ago
BEDMINSTER, NJ / ACCESSWIRE / March 23, 2017 / CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...
- Capital Cube•6 days ago
Categories: Yahoo Finance Get free summary analysis CorMedix, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of CorMedix, Inc. – Becton, Dickinson and Company, Emergent BioSolutions Inc., Utah Medical Products, Inc., Tetraphase Pharmaceuticals, Inc. and Achaogen, Inc. (BDX-US, EBS-US, UTMD-US, TTPH-US and AKAO-US) that have also ... Read more (Read more...)
- MarketWatch•10 days ago
Shares of CorMedix Inc. plunged 22% in premarket trade Friday, after the biopharmaceutical company said it currently didn't have enough cash to fund operations through 2017, given expected clinical trial ...
CRMD : Summary for CorMedix Inc - Yahoo Finance
CorMedix, Inc. (CRMD)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Day's Range||1.63 - 1.77|
|52 Week Range||1.35 - 4.54|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.62|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|